Related Articles
Lentiviral-mediated siRNA targeted against osteopontin suppresses the growth and metastasis of gastric cancer cells
Suppressing tumourigenicity of prostate cancer cells by inhibiting osteopontin expression
Overexpression of osteopontin promotes resistance to cisplatin treatment in HCC
Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA
Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinoma